Virtus Investment Advisers, Inc. Cytokinetics Inc Transaction History

Virtus Investment Advisers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$26.88 - $83.49 $106,068 - $329,451	-3,946 Reduced 45.54%	4,718 $393,000
Q3 2023 Nov 08, 2023	BUY	$29.46 - $36.61 $21,211 - $26,359	720 Added 9.06%	8,664 $255,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $158,859 - $198,452	-4,870 Reduced 38.01%	7,944 $259,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $58,947 - $80,769	-1,767 Reduced 12.12%	12,814 $450,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $561,951 - $794,956	14,581 New	14,581 $706,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.